Work

Phase I experience with c-MET inhibitor XL880 administered orally to patients (pts) with solid tumors

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3526

Authors: J. P. Eder, E. Heath, L. Appleman, G. Shapiro, D. Wang, L. Malburg, A. x. Zhu, T. Leader, A. Wolanski, P. LoRusso

Institutions: Massachusetts General Hospital, The Barbara Ann Karmanos Cancer Institute, Dana-Farber Cancer Institute

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2241761252

Cites:

Cited by: 47

Related to: 10